inforMED
MalfunctionFPB

NA

Received Mar 4, 2026 · Event occurred Feb 4, 2026

Report 1416980-2026-00835 · MDR key 24512148

Device

Generic name

Filter, Infusion Line

Model number

2N3350

Catalog number

2N3350

Lot number

DR25I09017

Product problems

  • Failure to Prime
  • No Flow

Patient

NA · Unknown

  • No Clinical Signs, Symptoms or Conditions

Narrative

Additional Manufacturer Narrative

ADDITIONAL INFORMATION WAS ADDED TO A1, A2, A3A, A4-A6, B5, B6, B7, D10, H6 (UPDATE CODES) AND H11. A2, A3A, A4-A6, B5, B6, B7, D10: UPDATE THE NULL VALUE TO N/A. B5: IT WAS FURTHER CONFIRMED THAT THE ISSUE WAS BEING UNABLE TO FLUSH DURING PRIMING, PRIOR TO PATIENT CONNECTION. THERE WAS NO PATIENT INVOLVEMENT. NO ADDITIONAL INFORMATION IS AVAILABLE. H11: UPON RECEIPT OF ADDITIONAL INFORMATION, IN THE EVENT THESE DEVICES ARE UNABLE TO BE PRIMED, THE CLINICIAN CAN CHOOSE TO REPLACE THE DEVICE BY RETRIEVING A NEW ONE, OR IN THE EVENT OF AN EMERGENCY CONNECT A SYRINGE OR ADMINISTRATION SET DIRECTLY TO THE CATHETER. THEREFORE THERE IS NO POTENTIAL FOR HARM TO THE PATIENT IN THE EVENT OF INABILITY TO PRIME. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Additional Manufacturer Narrative

ADDITIONAL INFORMATION: D4 (LOT, EXPIRATION DATE, UDI), H4, H6 (UPDATE CODES), H11. D4: EXPIRATION DATE (UPDATE THE NULL VALUE TO N/A). H11: A BATCH REVIEW WAS CONDUCTED AND THERE WERE NO DEVIATIONS FOUND RELATED TO THIS REPORTED CONDITION DURING THE MANUFACTURE OF THIS LOT. THE DEVICES WERE DISCARDED; THEREFORE, A DEVICE ANALYSIS COULD NOT BE COMPLETED. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem

IT WAS REPORTED THAT AN UNSPECIFIED AMOUNT OF MICRO-VOLUME EXTENSION SETS WERE UNABLE TO BE FLUSHED. THIS WAS OBSERVED SETUP. THERE WAS NO REPORT OF PATIENT INJURY OR MEDICAL INTERVENTION ASSOCIATED WITH THIS EVENT. NO ADDITIONAL INFORMATION IS AVAILABLE.

Additional Manufacturer Narrative

SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.